The opioid epidemic is the public health crisis of our time. Opioid overdose deaths were 5 times higher in 2016 than 1999; more than 42 000 deaths in 2016 involved an opioid-the most for any year on record. 1 More Americans died from drug overdose in 2016 than during the entire Vietnam War, 2 and US life expectancy dropped for the second year in a row, 3 largely because of the impact of lethal drug overdose. Opioid overdose can involve illicit use (eg, heroin) or licit use with prescription drugs (eg, oxycodone). In 2014, opioids accounted for 92 262 emergency department (ED) visits for nonfatal drug poisoning, 4 and it is estimated that there are 30 nonfatal opioid overdoses for every fatal opioid overdose. 5 Many such nonfatal opioid overdoses are treated by emergency medical services or in EDs with naloxone, a lifesaving drug that can reverse the effects of opioids. Reversing an opioid overdose with naloxone will resuscitate an apneic patient, but only treats the toxicological problem of the opioid without incorporating the physiologic aspects of opioid use disorder (OUD) or addiction. Patients are especially vulnerable in the short period following resuscitation, and are at an increased risk of subsequent overdose if they use higher opioid doses while naloxone is still in their system. 6 In many instances, these patients leave the ED without follow-up with an addiction specialist or access to treatment.
Although the solution to the opioid epidemic will require a collaborative multidisciplinary and multifactorial approach, EDs can play a key role in reaching those with highest risk and greatest vulnerability through a ground-up approach. Historically, EDs have provided referral to outpatient treatment, but because of the neurological and behavioral changes in patients with opioid dependence, a more vigorous approach should be considered. One approach described in the literature and shown to be effective is a warm handoff consisting of the following 3-pronged approach: (1) a brief negotiation interview conducted by a certified recovery specialist, social worker, or peer consult, among others; (2) near immediate referral to and follow-up with addiction treatment service available in the patient's area; and (3) ED-initiated treatment with buprenorphine/naloxone. 5 This approach, tested in a randomized controlled trial, resulted in 78% of patients being involved in addiction treatment 30 days after randomization versus 37% of patients receiving only a referral. 7 Although this approach is effective, implementation in everyday clinical practice can be difficult because of logistical barriers. The inability to overcome these hurdles has resulted in many missed opportunities to effectively facilitate increased access to addiction treatment services. Many EDs do not have the specialized services or increased resources to address these challenges, despite bearing an increased overall burden. In this editorial, we seek to elaborate on the aforementioned recommendations and then describe current challenges and opportunities to providing a warm handoff to patients in EDs. Specific examples from unique experiences in Philadelphia, Pennsylvania, are provided to illustrate practical obstacles encountered in clinical practice.
The first step in a warm handoff is to conduct a brief negotiation interview to advise and encourage patients to seek treatment. This service can be provided by social work, a certified recovery specialist, or peer counselor with the goal of making the patient feel comfortable and providing a safe space for them to discuss their substance use issues. This interview consists of 4 components: raise the subject, provide feedback, enhance motivation, and negotiate and advise. 7, 8 Part of the brief negotiation interview should include discussion of potential treatments and supportive services by describing types of treatment programs available, including inpatient and residential programs, and outpatient services with office-based physicians who can prescribe buprenorphine/naloxone and other medication-assisted treatment (MAT). The choice of treatment and next steps should be patient-centric. Even if a patient refuses treatment initially, the certified recovery specialist or peer counselor can serve as an ongoing advocate or resource after discharge from the ED. It is essential that the ED-based warm handoff program has a well-defined and easily accessible network of treatment providers who are ready and able to receive referrals.
A key adjunct to the warm handoff process is near immediate MAT induction. The American Society of Addiction Medicine recommends medication for opioid withdrawal management over abrupt cessation of opioids. 9 Although there are 3 Food and Drug Administrationapproved medications to treat OUD (methadone, extended-release naltrexone, and buprenorphine/naloxone), buprenorphine/naloxone can be prescribed by any medical specialist-not only addiction specialists. Initiating patients on an opioid partial agonist such as buprenorphine helps reduce or avoid withdrawal symptoms and prevents a potential relapse that abrupt opioid withdrawal might cause.
We believe this 3-pronged approach could be implemented in EDs with a high burden of disease from OUD and overdose, but difficulties arise at each step of the way. When coordinating patients to outpatient addiction treatment services, many barriers exist, including the types of services available and insurance coverage restrictions. In Pennsylvania, state-level funding is disbursed through Single County Authorities that further coordinate care for people with Medicaid and implement related programs within the county. However, issues arise as patients may not be eligible for services outside of the home county listed on their official ID, regardless of their current place of residence. Seeking to provide additional resources, the Pennsylvania Department of Health Services funded Centers of Excellence to provide holistic and supportive treatment services, several of which are available to EDs and other health outlets. Although the program design is well intentioned, it falls short of meeting the unique needs and circumstances of patients with near fatal overdose. In Philadelphia County, where overdose rates are high and multiple EDs function in a dense geographic area, Centers of Excellence services for recently reversed patients are not always embedded in EDs around the clock, but rather function on a consult basis during a finite time period, unlike the 24-hour nature of EDs.
Even if appropriate treatment options are obtained and patients are willing to seek addiction treatment services, it can be difficult to bridge them with ED-initiated buprenorphine/naloxone. A major obstacle to prescribing buprenorphine/naloxone is the dearth of workforce who have obtained a federally mandated X-waiver-a specific training that allows providers to prescribe MAT. According to the Substance Abuse and Mental Health Services Administration, approximately 44 155 physicians have completed the waiver, 10 which represents less than 5% of all US physicians. 11 Health systems can invest in workforce development by providing waiver training for all providers, including those in graduate medical education who serve this patient population.
In the wake of the opioid epidemic, health care providers and health systems must redefine the paradigm for treating those with OUD, and reinvent delivery of care to meet the needs of the patients. The ED is uniquely positioned to link patients who have suffered from a nonfatal opioid overdose to outpatient treatment with addiction specialists. Although most EDs have not been supplied with the resources to do this, many emergency medicine providers have worked to address the needs of their patients with OUD. With external support and investment, EDs can greatly increase their effectiveness and efficiency in capitalizing on potentially fleeting opportunities to engage those high-risk individuals with OUD into treatment and recovery. Although solving the opioid epidemic on a national scale will involve many stakeholders, EDs are critical partners and will be essential to long-term success.
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